Poll: Only Half of Older Adults Have Heard of the New RSV Vaccines, Arexvy and Abrysvo
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Aug. 28, 2023 -- About half of older adults (52 percent) have heard of the new vaccines against respiratory syncytial virus (RSV), Arexvy and Abrysvo, according to the National Poll on Healthy Aging released online on Aug. 22.
The poll, which comes from the University of Michigan in Ann Arbor, was administered July 17 through Aug. 7 to 1,850 people aged 60 to 80 years.
The poll showed that 21 percent of respondents said they were very interested, and another 43 percent said they were somewhat interested. However, only 41 percent of older adults who reported their health as fair or poor had heard of the RSV vaccines versus 53 percent of those who rated their health as good to excellent. Regardless of whether or not they had previously heard of the vaccines before the poll, more than 65 percent of those with a chronic health condition said they were very or somewhat interested in getting an RSV vaccine.
"As we prepare for the first RSV season when vaccines will be available for older adults, these early data suggest a need for public health officials, primary care providers, pharmacies, and others to target their outreach and awareness-building efforts," poll senior advisor Preeti Malani, M.D., from the University of Michigan, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
U.S. Government to Pay Moderna $176 Million to Develop mRNA Flu Vaccine
TUESDAY, July 2, 2024 -- U.S. health officials announced Tuesday that the federal government will pay Moderna $176 million to speed development of a pandemic flu vaccine based on...
CDC Advises Updated COVID Vaccine for Everyone Over 6 Months of Age
FRIDAY, June 28, 2024 -- As a summer wave of COVID infections rolls across the country, U.S. health officials have recommended that all Americans over the age of 6 months get one...
CDC Strengthens RSV Vaccine Advice for Those Over 75
THURSDAY, June 27, 2024 -- In new vaccination guidance issued Wednesday, U.S. health officials now recommend that all Americans aged 75 and older get an RSV vaccine before fall...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
